Acasti Pharma reported $-2.31M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Acasti Pharma USD -2.31M 1.38M Dec/2025
Addus HomeCare USD 30.35M 405K Sep/2025
Amarin USD -852K 7.26M Dec/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Option Care Health USD 68.97M 109K Sep/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Tilray USD -39.96M 39.19M Sep/2025